Outcome and Determinants of Failure to Complete 6-8 Cycles of Primary R-CHOP Treatment for Reasons Unrelated to Progression Among Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

Smedby Karin Ekstrom; Harrysson Sara; Andersson Per-Ola; Enblad Gunilla; Ekberg Sara; Jerkeman Mats; Eloranta Sandra

首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Outcome and Determinants of Failure to Complete 6-8 Cycles of Primary R-CHOP Treatment for Reasons Unrelated to Progression Among Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

【24h】

Outcome and Determinants of Failure to Complete 6-8 Cycles of Primary R-CHOP Treatment for Reasons Unrelated to Progression Among Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

机译：未能完成6-8个初级R-Chec治疗循环的结果和决定因素，原因与弥漫性大B细胞淋巴瘤（DLBCL）无关的原因与进展无关

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Blood: The Journal of the American Society of Hematology》 |2018年第novaelatreatmentappr期|共3页
作者
Smedby Karin Ekstrom; Harrysson Sara; Andersson Per-Ola; Enblad Gunilla; Ekberg Sara; Jerkeman Mats; Eloranta Sandra;
展开▼
作者单位

Karolinska Univ Hosp Dept Hematol Stockholm Sweden;

Karolinska Inst Div Clin Epidemiol Dept Med Solna Stockholm Sweden;

Gothenburg Univ Sahlgrenska Acad Gothenburg Sweden;

Akad Univ Hosp Dept Oncol Uppsala Sweden;

Karolinska Inst Div Clin Epidemiol Dept Med Solna Stockholm Sweden;

Lund Univ Dept Oncol &

Pathol Inst Clin Sci Lund Sweden;

Karolinska Inst Div Clin Epidemiol Dept Med Solna Stockholm Sweden;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类血液及淋巴系疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Outcome and Determinants of Failure to Complete 6-8 Cycles of Primary R-CHOP Treatment for Reasons Unrelated to Progression Among Patients with Diffuse Large B-Cell Lymphoma (DLBCL) [J] . Smedby Karin Ekstrom, Harrysson Sara, Andersson Per-Ola, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：未能完成6-8个初级R-Chec治疗循环的结果和决定因素，原因与弥漫性大B细胞淋巴瘤（DLBCL）无关的原因与进展无关
2. Responses and Cardiotoxicity with R-CDOP and R-CHOP Observed in Frontline Therapy for Patients with Primary Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL): A Randomized Phase-IV Study from Multiple Centers in China [J] . Feng Lili, Chu Xiaoxia, Zhao Hongguo, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：对初级弥漫性大B细胞淋巴瘤（DLBCL）和卵泡淋巴瘤（FL）的患者前线治疗中观察到R-CDOP和R-Chect的反应和心脏毒性：来自中国多个中心的随机期 - IV研究
3. Switching Fractioned R-CHOP Cycles to Standard R-CHOP Cycles Guided by Endoscopic Ultrasonography in Treating Patients with Primary Gastric Diffuse Large B-Cell Lymphoma [J] . Yizhen Liu, Yumei Liu, Ping Zhao, Cancer Management and Research . 2020,第4期

机译：将分馏的R-Chec循环切换到通过内镜超声引导的标准R-Chec循环，治疗原发性胃弥漫性大B细胞淋巴瘤患者
4. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
5. Switching Fractioned R-CHOP Cycles to Standard R-CHOP Cycles Guided by Endoscopic Ultrasonography in Treating Patients with Primary Gastric Diffuse Large B-Cell Lymphoma [O] . Yizhen Liu, Yumei Liu, Ping Zhao, 2020

机译：将分馏的R-Chec循环切换到通过内镜超声引导的标准R-Chec循环治疗原发性胃弥漫性大B细胞淋巴瘤患者
6. Treatment outcomes and pattern of failure in primary gastric diffuse large B cell lymphoma with complete remission following R-CHOP chemotherapy [O] . H.J. Kang, B.-O. Choi, S.-E. Jung, 2019

机译：r-chop化疗后，原发性胃弥漫性大B细胞淋巴瘤的治疗结果和失败模式

Outcome and Determinants of Failure to Complete 6-8 Cycles of Primary R-CHOP Treatment for Reasons Unrelated to Progression Among Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

著录项

相似文献

相关主题

期刊订阅